Immunogenicity in Clinical Practice and Drug Development: When is it Significant?

MeSH terms

• Adaptive Immunity / drug effects*
• Biological Products / administration & dosage
• Biological Products / immunology*
• Drug Development / methods*
• Drug Development / standards
• Drug Monitoring / methods
• Drug Monitoring / standards
• Drug-Related Side Effects and Adverse Reactions / diagnosis
• Drug-Related Side Effects and Adverse Reactions / epidemiology
• Drug-Related Side Effects and Adverse Reactions / immunology*
• Drug-Related Side Effects and Adverse Reactions / therapy
• Humans
• Models, Immunological*
• Monitoring, Immunologic / methods
• Monitoring, Immunologic / standards
• Risk Assessment / methods
• Risk Assessment / standards
• Societies, Scientific / standards
• United States
• United States Food and Drug Administration / standards